“As such, in the event that members of management or the board are implicated in any such legal proceedings, we may consider recommending that shareholders withhold votes from certain directors on that basis. Nevertheless, we will continue to monitor these issues going forward,” it said. ICICI Bank holds 79.22 per cent stake in ICICI Securities.
The annual general meeting of shareholders is scheduled on August 30.
Glass Lewis and ISS made headlines recently when they recommended to HDFC shareholders to not elect Deepak Parekh as a director of the company. After this, almost a quarter of the foreign portfolio investors voted against Parekh. Both proxy firms also recommended that shareholders should vote against two other HDFC directors Bimal Jalan
and Bansi Mehta as both were older than 75 years, and the former’s attendance in board meetings was low. Both of them resigned before the HDFC shareholders’ meeting.
Kochhar, is currently under investigation by the Securities and Exchange Board of India (Sebi) for a case relating to a loan extended by the bank to the Videocon Group. In 2012, ICICI Bank extended a loan of Rs 3.25 billion to Videocon. After the loan was granted, Kochhar’s husband’s firm, NuPower Renewables, received a Rs 640-million loan from Videocon’s promoter through a series of investment vehicles, allegedly as a quid pro quo. In 2017, it was reported that almost 86 per cent of the loan granted to Videocon remained unpaid and was declared a non-performing asset by ICICI Bank, the proxy firm said.
After denying any conflict of interest soon after the news
broke, the ICICI Bank board later set up an independent panel, led by former Supreme Court judge B N Srikrishna to probe all the charges. The board also sent Kochhar on an indefinite leave.
On Thursday, ICICI Bank Chairman, G C Chaturvedi said in Delhi the board was awaiting the Srikrishna committee’s report to reply to Sebi. On the other hand, after filing a preliminary enquiry early this year, the Central Bureau of Investigation has not made any comments.